Sharekhan

BUY NOW Buy Shelter Pharma Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Shelter Pharma Ltd

Tue 7/10/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Shelter Pharma Ltd

Your Vote -

Buy

40.00%

Hold

20.00%

Sell

40.00%

40.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities

    3 Oct 2025, 5:47PM 11,28,000 Equity Shares allotted pursuant to conversion of warrants

  • Shelter Pharma - Board Meeting Outcome for 11,28,000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.

    3 Oct 2025, 5:45PM 11,28,000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities

    1 Oct 2025, 6:05PM 13,14,000 Equity Shares allotted Pursuant to Conversion of Warrants

  • Shelter Pharma - Board Meeting Outcome for Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.

    1 Oct 2025, 5:59PM 13,14,000 Equity shares allotted pursuant to conversion of fully paid warrants.

  • Shelter Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 5:45PM Declaration of Voting Result and Scrutinizer Report

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    30 Sep 2025, 5:20PM Intimation Regarding Appointment of Secretarial Auditor of the Company at 18th Annual General Meeting held on 30th September, 2025

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    30 Sep 2025, 5:14PM Intimation Regarding Appointment of Statutory Auditor of the Company at 18th Annual General Meeting Held on 30th September, 2025

  • Shelter Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2025, 5:07PM Proceedings of 18th Annual General Meeting held on Tuesday, 30th September, 2025

  • Shelter Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 5:45PM Declaration of Voting Result and Scrutinizer Report

  • Shelter Pharma - Intimation Of Shelter Pharma'S Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing Re

    23 Sep 2025, 12:52PM Shelter Pharma Limited is participating as an exhibitor at the Ayush India Expo-05th Edition

  • Shelter Pharma - Shelter Pharma Limited Embarks On Sustainability Journey With The Installation Of A 15 KW Solar Power Plant

    22 Sep 2025, 1:36PM Solar Panel Installation of 15 MW

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    2 Sep 2025, 12:30PM Appointment of M/S Alvi & Associates for the period of 5 Years, in place of resigning Auditor, subject to approval of Members at the 18th AGM

  • Shelter Pharma - Approved Tuesday, 23Rd September , 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Enti

    2 Sep 2025, 12:23PM Approved 23rd September, 2025 as a record date for the purpose of E-voting and Dividend Entitlement

  • Shelter Pharma - To Close The Register Of Members Of The Company From Wednesday, 24Th September, 2025 To Tuesday, 30Th Septem

    2 Sep 2025, 12:20PM Dividend Entitlement

  • Shelter Pharma - The 18Th Annual General Meeting Of The Company Will Be Held On Tuesday, 30Th September, 2025 At 10:00 A.M. A

    2 Sep 2025, 12:15PM 18th Annual General Meeting will be held on 30th September, 2025

  • Shelter Pharma - Corporate Action-Board approves Dividend

    2 Sep 2025, 12:10PM Board has approved dividend @ 3.5% (Rs. 0.35/-) Per equity shares subject to approval of member at the 18th AGM scheduled to be held on 30th September

  • Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday, 02Nd\r\nSeptember, 20

    2 Sep 2025, 12:05PM Outcome of Board Meeting of The Company Held on the Tuesday, 02nd September, 2025

  • Shelter Pharma - Board Meeting Intimation for Intimation Regarding Meeting Of The Board Of Directors Of The Company That Will

    27 Aug 2025, 3:52PM Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and a

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    25 Aug 2025, 12:33PM Intimation with regards to Shelter Pharma Secured Order from Taha Drugs & Chemical Co. Ltd Pursuant to Regulation 30 of SEBI ( Listing Obligation and

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

    20 Aug 2025, 6:42PM Intimation of Resignation of Statutory Auditor of the company w.e.f 20th August, 2025

  • Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended August 05, 2025

    11 Aug 2025, 7:41PM As of August 2025, 52.32% is owned by Indian Promoters and 47.68% by Public. <p align=justify> Top five Promoters holding highest number of shares of

  • Shelter Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -

    8 Aug 2025, 10:28AM Intimation Under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements ) Regulations, 2015 - Selection of Veterinary Products for Sup

  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Allotment

    6 Aug 2025, 11:25PM Allotment of 88,08,000 Warrants on Preferential Basis

  • Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Dated 06Th August, 2025 For Allotment Of 88,08,000 Warra

    6 Aug 2025, 11:22PM Outcome of Board Meeting dated 06th August, 2025 for Allotment of 88,08,000 Warrants

  • Shelter Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    24 Jul 2025, 11:20AM Declaration of Voting Result and Scrutinizer Report

  • Shelter Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM

    23 Jul 2025, 1:29PM Proceeding of 01/2025-26 Extra Ordinary General Meeting

  • Shelter Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jul 2025, 2:49PM Submission of Certificate under Regulation 74(5) of Securities and Exchange Board of India ( Depositories and Participants) Regulations, 2018 for Quar
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Shelter Pharma Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 43.7647 36.3931 16.2947 8.9366 7.1865
Liabilities 43.7647 36.3931 16.2947 8.9366 7.1865
Equity 11.5598 11.5598 7.7438 0.4839 0.4839
Gross Profit 10.0677 8.5714 8.0574 2.9223 0.1801
Net Profit 7.2374 6.2002 5.7833 1.8569 0.0509
Cash From Operating Activities 5.4822 -1.8502 0.0033 0 0
NPM(%) 14.28 15.49 15.99 6.17 0.22
Revenue 50.6602 40.0229 36.1527 30.0554 22.4834
Expenses 40.5925 31.4515 28.0953 27.1331 22.3032
ROE(%) 18.91 16.2 15.11 4.85 0.13

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 783.30 -0.79 71.21 25.90 301.39 0.64
Lotus Eye Hospital and Institute Ltd 120.50 -2.03 394.42 94.37 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.15 0.38 0.00 195.95 -39.50 0.00
Astec Lifesciences Ltd 790.00 -1.00 0.00 89.00 -604.77 0.00

Company Info

The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.

The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.

Read More

Parent Organisation

Shelter Pharma Ltd.

Founded

12/10/2007

Managing Director

Mr.Mustaqim Nisarahmed Sabugar

NSE Symbol

FAQ

The current price of Shelter Pharma Ltd is

The 52-week high for Shelter Pharma Ltd is

The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.

The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT